uniQure N.V. SEC filings QURE
uniQure N.V. has 953 filings in SEC EDGAR's recent list, going back to Nov 8, 2013. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 27, 2026 | — |
| DEF 14A | Proxy statement | Apr 27, 2026 | Jun 10, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 16, 2026 | Jun 10, 2026 |
| DEFA14A | Additional proxy material | Apr 28, 2025 | — |
| DEF 14A | Proxy statement | Apr 28, 2025 | Jun 11, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 16, 2025 | Jun 11, 2025 |
| DEFA14A | Additional proxy material | Apr 24, 2024 | — |
| DEF 14A | Proxy statement | Apr 24, 2024 | Jun 18, 2024 |
| PRE 14A | Preliminary proxy statement | Apr 12, 2024 | Jun 18, 2024 |
| DEFA14A | Additional proxy material | Oct 6, 2023 | — |
| DEF 14A | Proxy statement | Oct 6, 2023 | Nov 15, 2023 |
| DEFA14A | Additional proxy material | Apr 28, 2023 | — |
| DEF 14A | Proxy statement | Apr 28, 2023 | — |
| PRE 14A | Preliminary proxy statement | Apr 18, 2023 | — |
| DEF 14A | Proxy statement | Apr 29, 2022 | Jun 14, 2022 |
| PRE 14A | Preliminary proxy statement | Apr 19, 2022 | Jun 14, 2022 |
| DEF 14A | Proxy statement | Sep 17, 2021 | Oct 21, 2021 |
| DEF 14A | Proxy statement | Apr 30, 2021 | Jun 16, 2021 |
| PRE 14A | Preliminary proxy statement | Apr 20, 2021 | Jun 16, 2021 |
| DEF 14A | Proxy statement | Nov 2, 2020 | Dec 1, 2020 |
| DEFA14A | Additional proxy material | Jun 15, 2020 | — |
| DEF 14A | Proxy statement | Apr 29, 2020 | Jun 17, 2020 |
| PRE 14A | Preliminary proxy statement | Apr 17, 2020 | Jun 17, 2020 |
| DEF 14A | Proxy statement | May 10, 2019 | Jun 19, 2019 |
| PRE 14A | Preliminary proxy statement | Apr 29, 2019 | Jun 19, 2019 |
| DEF 14A | Proxy statement | Sep 26, 2018 | Oct 24, 2018 |
| DEFA14A | Additional proxy material | May 31, 2018 | — |
| DEF 14A | Proxy statement | Apr 30, 2018 | Jun 13, 2018 |
| PRE 14A | Preliminary proxy statement | Apr 20, 2018 | Jun 13, 2018 |
| DEF 14A | Proxy statement | Aug 15, 2017 | Sep 14, 2017 |
| DEF 14A | Proxy statement | May 1, 2017 | Jun 14, 2017 |
| PRE 14A | Preliminary proxy statement | Apr 18, 2017 | Jun 14, 2017 |
Showing 32 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- QURE (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Amsterdam
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1590560
- Former names
- uniQure B.V. (until Feb 6, 2014)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.